Clinical trial
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
NCT01611935
Study timeline
Study start (actual)2013-05-01Date precision: day
Registry last updated2019-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Traumatic Shockunresolved
Interventions
VasopressinDRUG
Sponsors & collaborators
University of Pennsylvanialead sponsor
National Trauma Research Institutecollaborator
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01611935 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.